2nd Annual MA CRO/CMO Symposium
The second annual MA CRO/CMO Symposium, taking place Monday, Feb. 25 at the Boston Marriott in Newton, will shine a spotlight on the strength and success of the CRO and CMO communities in the Commonwealth.
The goal of the symposium is to bring together the biophamaceutical industry and the Massachusetts CRO/CMO cluster – which provides the scientific external resources required to support a virtual and semi-virtual company from conception through commercialization – and showcase the roles these types of partnerships are playing in accelerating drug development.
The event will allow attendees to evaluate the best alternatives that have evolved in shortening time to market. A series of case studies, interactive panel discussions and networking sessions will provide ample time to explore the various techniques and approaches being used by both virtual and established companies.
Keynote speakers will be Jose-Maria Fernandez, a researcher at the MIT Sloan Laboratory for Financial Engineering, and Janice Bourque, the managing director of Life Sciences at Hercules Technology Growth Capital – a specialty finance company providing secured loans and equity financing solutions to venture capital and private equity firms, and small-cap public life science companies at all stages of development. The company has committed $2.9 billion to more than 200 life science, technology and clean tech companies.
Bourque has more than 25 years of life science experience and focuses on emerging growth-stage life science companies. Before joining Hercules in 2010, Bourque provided strategic corporate investor fundraising for Commons Capital and Oxford Bioscience Partners to create a global health fund focused on innovative healthcare investments for emerging and developing countries. She also was senior vice president and group head-life sciences for Comerica Bank for four years and served as MassBio’s president & CEO for 12 years. She has been named one of Boston Magazine’s 100 most influential women and Newton Living’s 10 most influential women. She also serves as Emeritus Director of the MIT Koch Institute for Integrative Cancer Research.
Fernandez’s recent work has focused on the creation of new models to finance scientific research. More specifically, along with Professor Andrew Lo and Dr. Roger Stein, he has applied the principles of structured finance and portfolio theory to design a new type of biomedical investment vehicle
that issues research based obligations to finance the development of new cures for cancer. Prior to his work at MIT, he worked in debt capital markets for more than 10 years.
An exhibition area will connect attendees with companies that offer services from research to commercial manufacturing. The event will conclude with a networking reception.
For more information, contact Elizabeth Steele at 617-674-5100 or email@example.com.